The Third Circuit sent Uber Black Drivers on a nice trip back to district court yesterday when the court resuscitated the drivers’ claims that Uber misclassified them as independent contractors instead of employees under the Fair Labor Standards Act and Pennsylvania law. The appellate court reversed the district court’s grant of summary judgment in favor of the transportation behemoth and remanded the case to the Eastern District of Pennsylvania for resolution of various disputed issues of material fact. The Third Circuit undertook a searching review of the record, noting...Read Full Article >
The New York City Commission on Human Rights inked a settlement with Prada this month that will have the company investing significant human capital and resources in programs directed at diversity and inclusion. Is this settlement, which addresses the impact of racially tone-deaf expression, just the beginning of a new trend?
Over a year after Prada marketed its “Pradamalia” campaign—featuring a figurine of a monkey that resembled blackface—the company entered into an agreement obligating it to take key measures to combat racism within not only its ranks but also...Read Full Article >
Coming at a crucial time in the 5G rollout, the impact of the COVID-19/Wuhan Coronavirus on the electronics supply chain is real, expected to affect shipment targets and revenue. Both Qualcomm and MediaTek have raised concerns about their 5G SoC shipment targets, with MediaTek predicting a potential 15% drop in global 5G phone-related shipments. In addition to the very real effect on factory operation, the inability to travel and hold scheduled in-person meetings is going to further dampen the launch of 5G. The most public example of that being...Read Full Article >
Now that the nCoV coronavirus is a worldwide epidemic, the international community will likely be forced again to address the issues created by intellectual property ownership of potential vaccines and symptom treatments. The last two worldwide epidemics – H1N1 and Zika – exposed many problems and fewer solutions to the question of how to handle proprietary rights and research. The rush to apply existing drugs to treat symptoms of nCoV recalls the TamiFlu spike in the H1N1 epidemic, which involved the U.S. directly purchasing doses, resulting in a significant...Read Full Article >